Y.S.P.SOUTHEAST ASIA HOLDING

KLSE (MYR): YSPSAH (7178)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

2.41

Today's Change

+0.01 (0.42%)

Day's Change

2.41 - 2.41

Trading Volume

1,000

Financial
Market Cap

Market Cap

342 Million

NOSH

142 Million

Latest Quarter

Latest Quarter

30-Jun-2024 [#2]

Announcement Date

20-Aug-2024

Next Quarter

30-Sep-2024

Est. Ann. Date

21-Nov-2024

Est. Ann. Due Date

29-Nov-2024

QoQ | YoY

-76.87% | -74.15%

T4Q Result

Revenue | NP to SH

364,545.000 | 31,154.000

RPS | P/RPS

257.00 Cent | 0.94

EPS | P/E | EY

21.96 Cent | 10.97 | 9.11%

DPS | DY | Payout %

11.00 Cent | 4.56% | 50.08%

NAPS | P/NAPS

2.81 | 0.86

QoQ | YoY

-22.76% | -22.25%

NP Margin | ROE

8.65% | 7.82%

F.Y. | Ann. Date

30-Jun-2024 | 20-Aug-2024

Latest Audited Result

Latest Audited Result

31-Dec-2023

Announcement Date

23-Apr-2024

Next Audited Result

31-Dec-2024

Est. Ann. Date

23-Apr-2025

Est. Ann. Due Date

29-Jun-2025

Annual (Unaudited)

Revenue | NP to SH

354,995.000 | 37,315.000

RPS | P/RPS

250.27 Cent | 0.96

EPS | P/E | EY

26.31 Cent | 9.16 | 10.92%

DPS | DY | Payout %

10.00 Cent | 4.15% | 38.01%

NAPS | P/NAPS

2.79 | 0.86

YoY

8.27%

NP Margin | ROE

10.66% | 9.43%

F.Y. | Ann. Date

31-Dec-2023 | 27-Feb-2024

Annualized Result

Revenue | NP to SH

369,532.000 | 34,064.000

RPS | P/RPS

260.52 Cent | 0.93

EPS | P/E | EY

24.02 Cent | 10.04 | 9.96%

DPS | DY | Payout %

-

NAPS | P/NAPS

-

QoQ | YoY

-38.43% | -26.56%

NP Margin | ROE

9.41% | 8.55%

F.Y. | Ann. Date

30-Jun-2024 | 20-Aug-2024

Business Process

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 0 / 4 0.00% 0 / 8 0.00%
Total Positive Profit Years 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Positive Profit 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Profit Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted EPS Growth 0 / 4 0.00% 0 / 8 0.00%
Total Dividend Years 1 / 4 25.00% 2 / 8 25.00%
Continuous Quarters Of Dividend 1 / 4 25.00% 1 / 8 12.50%
Continuous Quarters Of Dividend Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted Dps Growth 1 / 4 25.00% 1 / 8 12.50%
Average ROE 1.95% 2.31%
Average Net Profit Margin 8.26% 9.92%

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Quarters Of Revenue Growth 2 / 5 40.00% 2 / 10 20.00%
Total Positive Profit Years 5 / 5 100.00% 10 / 10 100.00%
Continuous Quarters Of Positive Profit 5 / 5 100.00% 10 / 10 100.00%
Continuous Quarters Of Profit Growth 2 / 5 40.00% 2 / 10 20.00%
Continuous Quarters Of Adjusted EPS Growth 2 / 5 40.00% 2 / 10 20.00%
Total Dividend Years 5 / 5 100.00% 10 / 10 100.00%
Continuous Quarters Of Dividend 5 / 5 100.00% 10 / 10 100.00%
Continuous Quarters Of Dividend Growth 2 / 5 40.00% 2 / 10 20.00%
Continuous Quarters Of Adjusted Dps Growth 2 / 5 40.00% 2 / 10 20.00%
Average ROE 7.31% 8.16%
Average Net Profit Margin 8.30% 9.30%
Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 364,545 369,532 354,995 277,631 312,756
NP to SH 31,154 34,064 37,315 25,573 26,390
Dividend 15,602 31,205 14,182 10,917 11,952
Adjusted EPS 21.96 24.02 26.31 18.03 18.60
Adjusted DPS 11.00 22.00 10.00 7.70 8.43

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.

Growth

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue -29.91% -4.38% 5.45% -16.46% -14.85%
NP to Owner -76.87% -74.15% -26.56% -58.91% -64.06%
Dividend 0.00% 10.40% 10.40% 300.00% 319.77%
Adjusted EPS -76.82% -74.10% -26.55% -58.85% -63.99%
Adjusted DPS 0.00% 10.40% 10.40% 300.00% 319.77%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue 2.69% 16.56% 31.31% 4.09% 18.15% 33.10% 6.21% 13.51% 27.87%
NP to Owner -16.51% 18.05% 21.82% -8.71% 29.08% 33.20% 8.27% 41.40% 45.91%
Dividend 10.02% 30.54% 42.91% 120.03% 161.08% 185.82% 25.71% 18.66% 29.90%
Adjusted EPS -16.52% 18.03% 21.80% -8.69% 29.11% 33.23% 8.27% 41.40% 45.91%
Adjusted DPS 10.02% 30.54% 42.91% 120.03% 161.08% 185.82% 25.71% 18.66% 29.90%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Discussions
6 people like this. Showing 50 of 2,085 comments

ValueMe

Hold sampai tumbuh janggut putih.Kihkihkih.

2021-09-18 15:04

Lightofheaven

Hold for lomg term.
2 years like that.
You will thanks me.
Just a cup of starbuck belanja me.

2021-09-22 11:31

wallstreetrookie

Initiate position

2021-10-04 16:31

maska

more medicine supply

2022-01-24 15:46

wallstreetrookie

Guide to Investing in Bursa Healthcare 2022
1. Kotra Industries 2. YSP 3. ???

2022-04-02 21:53

UnicornP

Agreed with csan. Undervalued and going to be more undervalued!

2022-09-15 15:09

UnicornP

Creeping up

2022-10-31 10:32

wallstreetrookie

Buy-side has no more idea. They will pump all the healthcare stocks remaining

2022-11-04 11:22

wallstreetrookie

Just look at all the non-glove companies. They are all green

2022-11-04 11:22

UnicornP

Gross got up a bit, still good. Confident prospect.

2022-11-22 19:32

UnicornP

csan sell call

2022-12-01 16:40

Lightofheaven

Yes. Yes. Yes
Hold until next year Autumn for great harvest

2022-12-05 09:57

Lightofheaven

Y.S.P remain strong and healthy..all the way towards 2023

2022-12-12 16:23

Lightofheaven

walao ehh..wat happen to YSP
Suddenly surge to fly so high today!! Happy Happy

2022-12-13 12:48

Thkent91

Finally this share has released it's true potential power. I have been waiting years for it to shine

2023-01-03 19:55

wallstreetrookieNEW

Apex Healthcare + YSP + Kotra Industries = Dream Healthcare Portfolio 2023

2023-02-23 16:34

wallstreetrookieNEW

All in

2023-02-23 16:34

pang72

QR gostan?
So, largely pump and dump for HEALTHCARE recently

2023-02-27 19:11

value_seeker

Is the breakout sustainable?

2023-02-27 20:41

hhhiii123

What happen to the price when qtr result so good, any insider news?

2023-02-28 21:35

Nighelanghelo

someone keyed in 2.49 instead of 2.94?

2023-03-01 13:36

Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$€£¥

Security LastPr PE DY% Divcts ROE ttm-marg
YSPSAH (Pharmaceuticals) 2.35 9.63 3.4 8 9.25 10.3

2023-03-30 17:12

Lightofheaven

hold this for long term
hold this for dividen

2023-08-01 12:25

katara

good counter

2023-08-03 16:43

katara

no one interested?💙

2024-01-05 14:18

donald770

Qr result best ever. Should be due for upside rerating!!!

2024-05-22 15:53

BullishMarket

New Production line is started to be operated for the newly acquired factory premise. With the newly operated production line, the company's Revenue YoY % growth will be significantly increased within 2 years.

2024-05-22 18:51

Papayashot

Hi BullishMarket, from where you aware that New Production line is started to be operated for the newly acquired factory premise?

2024-05-22 20:15

SincereStock

bought a few at 2.85, acceptable bargain I think considering today open at RM3

2024-05-23 11:41

katara

mid term TP 330-450

2024-05-23 12:15

katara

today steady at 295😘

2024-05-23 16:34

katara

going to fly .. .. ..

2024-05-27 21:15

TiffanixLVxHermes

reasons to buy:
1. recorded highest revenue and profit in 20years
2. organic growth, hold patents (expect to continue deliver good result)
3. DY 3.5% above RM0.11 ex 24/6/24

let's monitor
😎

2024-06-04 15:45

xiaoeh

Dear TLVH
may i know your entry price...?

2024-06-04 16:02

TiffanixLVxHermes

above 2.90 😎

2024-06-04 16:07

xiaoeh

Noted and Thanks for your sharing👍

2024-06-04 16:12

Up_down

Yspsah has been all the while being the lowest valuation company against its peers like Ahealth & Dpharma.

2024-06-06 10:44

katara

next monday 11 sen ex😍

2024-06-19 16:35

katara

https://www.ctee.com.tw/news/20220714700772-439801
永信東南亞控股是台灣本土學名藥製藥廠中,第一家跨國上市的公司。這兩年,受疫情影響,年營收成長仍有3%〜5%。即將來臨的後疫情時代,李芳信預計,自2022年起,公司營收至少有雙位數以上的成長。

2 months ago

SincereStock

waiting for reinvestent of dividend fund on 22 july 2024

2 months ago

Learner68

Coming QR, looking forward for its new record high revenue and PBT...

1 month ago

Learner68

Disappointing QR. Looking forward for 2nd half performance then.

4 weeks ago

SincereStock

sold all YSPSAH at open price of 2.35 after very disaapointing QR (9.00am, 21 august 2024)

4 weeks ago

katara

fundamental will support share price at around 2.50 b4 next Q...

4 weeks ago

Learner68

For the first half of 2024, the Group's revenue rose 5.5% to RM184.8 million compared to RM175.2 million reported in the same period last year. The Group's profit before tax for 1H24 declined 17.0% to RM26.0 million from RM31.3 million in 1H23 due to higher unrealised foreign exchange loss was recorded resulted from strengthening of US Dollar.
Therefore, does that mean the stronger ringgit is in favour of YSP?

4 weeks ago

katara

For the first half of 2023, the Group recorded a profit before tax of RM31.3 million compared to RM24.4 million in the same period last year mainly due to higher sales
from domestic and overseas market and foreign exchange gain resulted from weakening of the Ringgit against the US Dollar.
--Q2 2023😁

3 weeks ago

Learner68

Katara, thanks! I guess it depends on the mix/geography of the sales. Anyway, good to see seriously buyback this round by Lees.

1 week ago

Post a Comment